Literature DB >> 11741389

Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.

M Watanabe1, M Dykes-Hoberg, V C Culotta, D L Price, P C Wong, J D Rothstein.   

Abstract

The mechanisms leading to neurodegeneration in ALS (amyotrophic lateral sclerosis) are not well understood, but cytosolic protein aggregates appear to be common in sporadic and familial ALS as well as transgenic mouse models expressing mutant Cu/Zn superoxide dismutase (SOD1). In this study, we systematically evaluated the presence of these aggregates in three different mouse models (G93A, G85R, and G37R SOD1) and compared these aggregates to those seen in cases of sporadic and familial ALS. Inclusions and loss of motor neurons were observed in spinal cords of all of these three mutant transgenic lines. Since a copper-mediated toxicity hypothesis has been proposed to explain the cytotoxic gain-of-function of mutant SOD1, we sought to determine the involvement of the copper chaperone for SOD1 (CCS) in the formation of protein aggregates. Although all aggregates contained CCS, SOD1 was not uniformly found in the inclusions. Similarly, CCS-positive skein-like inclusions were rarely seen in ALS neurons. These studies do not provide strong evidence for a causal role of CCS in aggregate formation, but they do suggest that protein aggregation is a common event in all animal models of the disease. Selected proteins, such as the glutamate transporter GLT-1, were not typically observed within the inclusions. Most inclusions were positively stained with antibodies recognizing ubiquitin, proteasome, Hsc70 in transgenic lines, and some Hsc70-positive inclusions were detected in sporadic ALS cases. Overall, these observations suggest that inclusions might be sequestered into ubiquitin-proteasome pathway and some chaperone proteins such as Hsc70 may be involved in formation and/or degradation of these inclusions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11741389     DOI: 10.1006/nbdi.2001.0443

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  147 in total

Review 1.  Complex genetics of amyotrophic lateral sclerosis.

Authors:  Catherine B Kunst
Journal:  Am J Hum Genet       Date:  2004-10-11       Impact factor: 11.025

2.  Structural basis of Cu, Zn-superoxide dismutase amyloid fibril formation involves interaction of multiple peptide core regions.

Authors:  Masataka Ida; Mizuho Ando; Masayuki Adachi; Asumi Tanaka; Kodai Machida; Kunihiro Hongo; Tomohiro Mizobata; Miho Yoshida Yamakawa; Yasuhiro Watanabe; Kenji Nakashima; Yasushi Kawata
Journal:  J Biochem       Date:  2015-08-29       Impact factor: 3.387

3.  Novel mutations that enhance or repress the aggregation potential of SOD1.

Authors:  Uma Krishnan; Marjatta Son; Bhagya Rajendran; Jeffrey L Elliott
Journal:  Mol Cell Biochem       Date:  2006-04-01       Impact factor: 3.396

4.  Impaired post-translational folding of familial ALS-linked Cu, Zn superoxide dismutase mutants.

Authors:  Cami K Bruns; Ron R Kopito
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

Review 5.  Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.

Authors:  Tessa Sinnige; Anan Yu; Richard I Morimoto
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 6.  The perplexing role of copper-zinc superoxide dismutase in amyotrophic lateral sclerosis (Lou Gehrig's disease).

Authors:  Soshanna Zittin Potter; Joan Selverstone Valentine
Journal:  J Biol Inorg Chem       Date:  2003-03-19       Impact factor: 3.358

7.  Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme.

Authors:  Mercedes Prudencio; Armando Durazo; Julian P Whitelegge; David R Borchelt
Journal:  J Neurochem       Date:  2008-12-11       Impact factor: 5.372

8.  A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration.

Authors:  Masataka Nakamura; Kevin F Bieniek; Wen-Lang Lin; Neill R Graff-Radford; Melissa E Murray; Monica Castanedes-Casey; Pamela Desaro; Matthew C Baker; Nicola J Rutherford; Janice Robertson; Rosa Rademakers; Dennis W Dickson; Kevin B Boylan
Journal:  Acta Neuropathol       Date:  2015-04-28       Impact factor: 17.088

9.  Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice.

Authors:  Chetan Vijayvergiya; M Flint Beal; Jochen Buck; Giovanni Manfredi
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

10.  HDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation.

Authors:  Jozsef Gal; Jing Chen; Kelly R Barnett; Liuqing Yang; Erin Brumley; Haining Zhu
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.